NCT04594733View on ClinicalTrials.gov

The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Fibromyalgia
Interventions
DRUG

minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo

minocycline (200 mg daily) and NAC (1200 mg daily) followed by placebo

DRUG

Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily)

Placebo followed by minocycline (200 mg daily) and NAC (1200 mg daily)

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT04594733 - The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia | Biotech Hunter | Biotech Hunter